Delic Labs Scientific Advisor Professor Glenn Sammis Receives Full Professorship at University of British Columbia

Published: August 12, 2021

Delic Labs Scientific Advisor Professor Glenn Sammis Receives Full Professorship at University of British Columbia

Delic Corp Inc., the leading psychedelic wellness platform, announced Professor Glenn Sammis, Scientific Advisor of its subsidiary Delic Labs has been granted a full professorship at the University of British Columbia as a member  of the Chemistry Department. Professor Sammis has further taken a twelve-month sabbatical from the University and will be devoting his time to working closely with Dr. Markus Roggen in developing intellectual property (IP) for Delic Labs’ cannabis and psilocybin research.

Delic Labs is a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Delic Labs serves as the engine for the DELIC platform, conducting research and developing innovative product lines and intellectual property (IP), including psilocybin vaporization technology for future distribution across the Company’s physical footprint and licensed psychedelic wellness clinics in the United States.

“It is a great honor to earn a full-time professorship in chemistry with the University of British Columbia,” said Delic Labs Scientific Advisor Professor Glenn Sammis. “I am excited to spend the coming months of my sabbatical conducting intensive research alongside Dr. Roggen as we build out valuable IP in the burgeoning cannabis and psychedelic medical spaces. Our unique and early testing of lesser-known compounds and practices will give us a first-mover advantage in the medical psychedelic space.”

Founded by award-winning chemist, Dr. Markus Roggen, and UBC Professor, Dr. Glenn Sammis, DELIC Labs supports the psychedelic industry with high precision chemical analytics,  metabolomic identification and process optimization. DELIC Labs is one of a handful of licensed psilocybin research labs in Canada and has an aggressive plan to build out a suite of novel compounds and delivery methods for the industry. DELIC Labs is also a leading cannabis analytical and research company boasting clients that include some of the largest brands in the world. DELIC Labs is applying for a Dealer’s License, and intends to eventually commercialize its psilocybin research and associated intellectual property (IP).

Dr. Sammis started his chemical education at Stanford University, receiving B.Sc. in Chemistry with Honors and Distinction in 1999. He then joined Prof. Eric Jacobsen at Harvard University as an NSF Predoctoral fellow and obtained a Ph.D. in Chemistry in 2004. After, he moved to Princeton University for a two-year NIH postdoctoral fellowship with Prof. Erik Sorensen. Dr. Sammis is now a Full Professor at the Chemistry Department at the University of British Columbia. He has built an internationally recognized research group working on the development of novel synthetic methods for the preparation of natural products and pharmaceuticals.

About Delic Labs (formerly Complex Biotech Discovery Ventures Ltd.)
Delic Labs  is a federally licensed cannabis and psilocybin research laboratory focused on extraction optimization, analytical testing, and process development. Based at the University of British Columbia in Vancouver, Canada and founded by award-winning chemists Dr. Markus Roggen and UBC Professor Dr. Glenn SammisDelic Labs uses precision chemical analytics and metabolomics identification to develop IP, produce novel products for patients, and advance the cannabis and psychedelic wellness industries. Part of the Delic Corp family, the leading psychedelic wellness platform, Delic Labs powers innovation and treatment options with an ever-expanding line of unique and high-quality products for markets that allow legal cannabis and psychedelic-based care.

About Delic Corp, Inc.
Delic  is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio, Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology, Meet Delic the premiere psychedelic wellness event, and Ketamine Infusion Centers one of the largest ketamine clinics in the country. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses.

Recent News

View All News Items

Latest Article

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

As the holiday season approaches, consumers across Canada are gearing up for festivities and gift-giving. While traditional retail industries have long capitalized on holiday consumer spending habits, the cannabis market is quickly establishing itself as a key player in this annual economic surge.

Read Article